Form 4: Zynex Inc. CEO Thomas Sandgaard Receives Restricted Stock Award
SEC Form 4 Filing
Thomas Sandgaard, CEO and Chairman of Zynex Inc., reports the acquisition of 6,912 shares of restricted stock with quarterly vesting over two years.
Summary
- Thomas Sandgaard, the President, CEO, and Chairman of Zynex Inc., filed a Form 4 on October 29, 2024, reporting changes in beneficial ownership of the company's stock.
- The report indicates that Sandgaard acquired 6,912 shares of common stock as a restricted stock award on October 29, 2024, at a price of $0 per share.
- These shares were issued under the company's 2017 Stock Incentive Plan and will vest equally on a quarterly basis over two years, starting one quarter from the grant date.
- Following the reported transaction, Sandgaard beneficially owns 21,196 shares of restricted stock awards that have not yet vested.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a stock award, which is a common practice in executive compensation.
Positives
- The grant of restricted stock aligns the CEO's interests with those of the shareholders, incentivizing long-term performance.
- The vesting schedule encourages continued service and commitment from the CEO.
Industry Context
Stock awards are a common form of executive compensation in the medical device industry, used to attract and retain talent and align management's interests with shareholder value.
Comparison to Industry Standards
- Executive compensation packages, including stock awards, vary significantly across the medical device industry depending on company size, performance, and stage of development.
- Comparing Zynex's executive compensation practices to those of similar-sized medical device companies would provide a more comprehensive assessment.
- Companies like Inogen and Livongo Health (prior to its acquisition by Teladoc) could serve as benchmarks for comparison.
Stakeholder Impact
- The stock award could positively impact shareholders by incentivizing the CEO to improve company performance.
- Employees may view the stock award as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 10/29/2024 | Date of earliest transaction: Grant date of restricted stock award. |
| 10/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.